HASSAN, S. S.; MUKHTAR, E. J. H. A.; MADLUM, K. N. Metabolic pathways inhibitors can affect the therapeutic efficiency of doxorubicin. International journal of health sciences, [S. l.], v. 6, n. S2, p. 9099–9108, 2022. DOI: 10.53730/ijhs.v6nS2.7375. Disponível em: https://sciencescholar.us/journal/index.php/ijhs/article/view/7375. Acesso em: 10 may. 2026.